By Dennis Thompson
SATURDAY, May possibly 23, 2020 (HealthDay Information) — Yet another COVID-19 vaccine applicant has attained excellent early benefits, a investigate team in China documented Friday.
The experimental vaccine developed essential indicators of immune response in a small group of grownups, a sign that it could potentially shield people today against COVID-19, scientists documented May possibly 22 on line in The Lancet professional medical journal.
“These benefits depict an essential milestone,” researcher Wei Chen, section of a team with the Beijing Institute of Biotechnology, explained in a journal news release.
“On the other hand, these benefits